7 Ways Estrogen Changes Can Affect Cardiovascular Health
Estrogen is usually associated with reproduction.
But estrogen receptors are also found throughout the cardiovascular system, including inside blood vessels.
That means changes in estrogen signaling can reach far beyond the menstrual cycle.
Researchers studied 132 healthy women ranging from premenopause through late postmenopause and measured flow-mediated dilation, or how effectively the brachial artery widened when blood flow increased. [1]
Average dilation was 9.9% in premenopausal women.
It fell progressively across the menopause transition:
Early perimenopause: 8.2%
Late perimenopause: 6.5%
Early postmenopause: 5.5%
Late postmenopause: 4.7%
The study cannot prove that estrogen alone caused the difference. Aging and other metabolic changes also occur during these years.
But the findings demonstrate that measurable cardiovascular changes can develop across the same transition in which ovarian estrogen production changes dramatically.
Here are seven ways estrogen changes can intersect with cardiovascular health.
1. Blood Vessels May Have More Difficulty Relaxing
The inside of every blood vessel is lined by a thin layer of cells called the endothelium.
One of its jobs is helping the artery determine when to widen.
Estrogen interacts with receptors in endothelial cells and can influence the production and activity of endothelial nitric oxide synthase, or eNOS.
This enzyme helps produce nitric oxide.
Nitric oxide then signals the smooth muscle surrounding the artery to relax.
As that muscle relaxes, the blood vessel widens and blood can move through with less resistance.
When estrogen signaling changes, this pathway may become less effective.
Human studies have found lower vascular nitric oxide activity after menopause, while experimental estrogen administration has been shown to increase nitric oxide-dependent vascular activity.
This helps explain why endothelial function has become an important area of cardiovascular research during the menopause transition.
It does not mean estrogen is the only factor controlling nitric oxide. Exercise, metabolic health, oxidative stress, smoking, blood pressure, and aging can all influence the same pathway.
But estrogen is one part of the signaling system that helps blood vessels respond appropriately when more blood flow is required. [2]
2. Arteries Can Become Stiffer
Healthy large arteries are designed to stretch.
When the heart contracts and pushes blood into the aorta, the arterial wall expands to absorb part of that force.
It then recoils between heartbeats.
That flexibility helps smooth the pressure created by each contraction.
Researchers from the Study of Women's Health Across the Nation examined arterial stiffness in 339 women around the time of their final menstrual period.
More than one year before the final menstrual period, carotid-femoral pulse-wave velocity increased by approximately 0.9% per year.
Within one year of the final menstrual period, the annual increase accelerated to approximately 7.5%.
Afterward, that accelerated rate was no longer observed.
The researchers concluded that the period surrounding the final menstrual period may be an important window for changes in vascular function.
Estrogen is not the only explanation. Changes in blood pressure, body composition, aging, and other cardiovascular risk factors also contribute.
But estrogen interacts with the endothelium, vascular smooth muscle, collagen, elastin, and other systems involved in arterial flexibility.
When arteries become stiffer, they absorb less of the pressure generated with each heartbeat.
More of that pressure can then travel forward through the vascular system. [3]
3. LDL Cholesterol And ApoB Can Rise Around Menopause
Cholesterol changes with age.
But researchers have found that some lipid changes appear to accelerate specifically around the final menstrual period.
The SWAN study followed more than 3,000 women through midlife.
Researchers examined cardiovascular risk factors over repeated annual visits to determine which changes were primarily associated with chronological aging and which appeared to track more closely with the menopause transition.
Three stood out:
Total cholesterol.
LDL cholesterol.
Apolipoprotein B, or ApoB.
All three showed substantial increases during the one-year period surrounding the final menstrual period.
ApoB is particularly important because each atherogenic particle—including LDL particles—contains one ApoB molecule.
That makes ApoB useful for estimating the number of cholesterol-carrying particles capable of entering the artery wall.
More recent SWAN research has also found that the steep increase in LDL during perimenopause is associated with later measures of carotid plaque.
Estrogen influences several parts of lipid metabolism, including how the liver handles cholesterol and lipoproteins.
As estrogen levels change, the lipid environment can therefore change with them.
This is one reason a cholesterol level that remained relatively consistent earlier in adulthood may begin moving differently around menopause. [4]
4. More Fat Can Begin Accumulating Around Internal Organs
The number on the scale does not tell you where body fat is being stored.
That distinction becomes especially important during menopause.
Subcutaneous fat sits underneath the skin.
Visceral fat develops deeper inside the abdomen around internal organs.
Visceral fat is more metabolically active and is associated with insulin resistance, inflammation, abnormal blood lipids, and cardiovascular risk.
In a longitudinal study following women through menopause, researchers found that only the women who became postmenopausal during follow-up showed a significant increase in visceral abdominal fat.
Their estradiol levels also fell significantly.
The SWAN Heart Study later examined 362 women and found that visceral fat began increasing more rapidly approximately two years before the final menstrual period.
During that period, visceral fat increased by approximately 8.2% per year.
After the final menstrual period, it continued rising at approximately 5.8% per year.
Importantly, greater menopause-related visceral fat accumulation was also associated with greater internal carotid artery wall thickness, a marker of subclinical vascular disease.
Estrogen appears to participate in how fat tissue is stored and metabolized, although activity levels, calorie intake, genetics, sleep, aging, and other hormones also affect body composition.
The change is therefore not simply about gaining weight.
A woman can experience a meaningful shift in where fat is stored, and that location can carry different cardiovascular consequences. [5]
5. Blood-Pressure Regulation Can Change
Blood pressure is controlled by much more than the heart.
The kidneys, nervous system, blood vessels, hormones, and several chemical signaling systems continuously work together to determine vascular resistance and blood volume.
Estrogen interacts with some of those systems.
One example is the renin-angiotensin-aldosterone system, or RAAS.
RAAS helps regulate blood-vessel constriction, sodium balance, fluid volume, and blood pressure.
Research suggests estradiol can modify several components of this pathway.
That has led scientists to study whether changing estrogen levels may contribute to differences in blood-pressure regulation around menopause.
The relationship is not simple.
Some longitudinal studies have found that much of the increase in blood pressure seen after menopause can also be explained by aging, body weight, abdominal fat, and other cardiovascular factors.
A 2026 longitudinal study of 526 women found several different blood-pressure trajectories across menopause. Lower estradiol was related to blood pressure within one subgroup, while body mass index and waist circumference were consistently important across the groups.
So it would be inaccurate to say that falling estrogen automatically causes high blood pressure.
A more accurate picture is that estrogen changes occur within a larger physiological transition that can alter several systems involved in blood-pressure control at the same time. [6]
6. The Structure Of The Artery Wall Can Change
Changes during menopause are not limited to how an artery functions.
Researchers have also measured changes in the physical structure of arterial walls.
In the SWAN study, investigators examined carotid arteries in 483 middle-aged women.
They measured the outer diameter of the artery and the thickness of its inner layers.
After accounting for traditional cardiovascular risk factors, lower estradiol was associated with a larger carotid artery adventitial diameter.
Women in late perimenopause also had larger arterial diameters than women who were premenopausal or in early perimenopause.
This type of enlargement may reflect vascular remodeling—the artery adapting structurally to changes in pressure, blood flow, aging, and the surrounding biological environment.
A separate longitudinal analysis followed women for as long as nine years.
The rate at which carotid intima-media thickness increased was approximately 0.005 to 0.007 millimeters per year during the earlier reproductive stages.
During late perimenopause, it increased to approximately 0.017 millimeters per year.
Researchers concluded that the carotid artery undergoes measurable structural adaptation during the menopause transition.
These changes happen gradually and cannot usually be felt.
But they demonstrate that the transition can involve physical changes inside the vascular system, not just changes in symptoms or hormone levels. [7]
7. Early Atherosclerotic Changes Can Progress Differently
Atherosclerosis develops when cholesterol-containing particles, inflammatory cells, and other material accumulate within the artery wall over time.
It does not appear suddenly.
The process can develop for years before cardiovascular symptoms occur.
Researchers have examined whether the menopause transition corresponds with changes in these early markers.
One study followed 203 women between ages 45 and 60 who did not have diagnosed cardiovascular disease.
Women underwent repeated carotid ultrasound examinations over three years.
The researchers found that women who moved more rapidly from premenopause to postmenopause experienced faster progression of carotid intima-media thickness than women whose transition occurred more slowly.
Another SWAN investigation found that the rate of carotid wall thickening increased during late perimenopause.
That does not prove estrogen loss directly creates atherosclerosis.
Atherosclerosis is influenced by LDL particles, blood pressure, smoking, diabetes, inflammation, genetics, age, body composition, and many other factors.
But several of those factors can begin changing during the same period in which estrogen patterns are changing.
That is what makes menopause an important cardiovascular transition.
It is not one hormone changing one system.
It is several cardiovascular systems beginning to move at the same time. [8]
The Bigger Picture
Estrogen changes do not automatically mean cardiovascular disease will develop.
And menopause itself is not a disease.
But the transition can coincide with measurable changes in blood-vessel function, arterial stiffness, cholesterol, abdominal fat distribution, blood-pressure regulation, and artery structure.
Some are related to ovarian aging.
Others are driven partly or primarily by chronological aging, lifestyle, genetics, metabolic health, and existing cardiovascular risk factors.
The important part is recognizing that cardiovascular health can begin changing before there are obvious symptoms.
That makes midlife an important time to pay attention to blood pressure, cholesterol, glucose regulation, physical activity, body composition, smoking status, and other established cardiovascular risk factors.
Understanding what is changing provides a clearer picture of why cardiovascular health deserves more attention during and after the menopause transition.
